LIFEOS GENOMICS CORPORATION
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
1. LifeOS Developed Assay Panels
2. Assay Co-Development
3. QLoci™ NIPT Assay Panel
4. Maximize your utility on the QLoci™ system.
2. Assay Co-Development
3. QLoci™ NIPT Assay Panel
4. Maximize your utility on the QLoci™ system.
The content above was translated by Ai
Founded Year
2015
Unified Business No.
24859657
Status
Active
Number of Employees
0
Total Paid-in
Capital
34,833,900 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
LifeOS Genomics is a biotechnology and in-vitro diagnostics company focused on IVD genetic testing using liquid biopsy. LifeOS Genomic’s flagship product, the QLoci System, is an automated genetic testing platform based on our novel multiplex digital PCR technology (mdPCR). By leveraging the unique high multiplexity and sensitivity of this PCR technology, LifeOS aims to decentralize and enable the routine practice genetic testing.
Founder Timothy Liu, Ph.D., assembled a team of experts in genetics, chemistry, automation, optics, and medical software to design and develop a medical device that focuses on the IVD experience. LifeOS is positioning the mdPCR platform as a testing solution for a myriad of genetic diseases, with promising applications in non-invasive prenatal testing, early cancer screening, companion diagnostics, infectious disease monitoring, and other areas requiring high multiplexity and high sensitivity.
Founder Timothy Liu, Ph.D., assembled a team of experts in genetics, chemistry, automation, optics, and medical software to design and develop a medical device that focuses on the IVD experience. LifeOS is positioning the mdPCR platform as a testing solution for a myriad of genetic diseases, with promising applications in non-invasive prenatal testing, early cancer screening, companion diagnostics, infectious disease monitoring, and other areas requiring high multiplexity and high sensitivity.
The content above was translated by Ai
